Simplify Logo

Full-Time

Manager – Metrology & Laboratory Systems Maintenance

Posted on 7/29/2024

Editas Medicine

Editas Medicine

201-500 employees

Develops gene editing treatments using CRISPR

Biotechnology
Healthcare

Senior

Cambridge, MA, USA + 1 more

More locations: Devens, MA, USA

This position will split time between Devens and Cambridge, MA for the remainder of 2024 and will be based full-time in Devens, MA starting January 2025.

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
Management
Requirements
  • BS degree in electrical, mechanical, or relevant engineering discipline with a minimum 5 years of Metrology and Laboratory System Maintenance experience supporting and troubleshooting.
  • Minimum 2 years experience managing personnel.
  • Thorough knowledge of cGMP in the pharmaceutical industry
  • Extensive knowledge of pharmaceutical, manufacturing and laboratory systems and equipment
  • Knowledge of IMTE (Inspection, Measurement, and Test Equipment), General understanding of control systems including PLCs, HMIs, Building Automation Systems, CCMS (Computerized Calibration Management Systems)
Responsibilities
  • Managing Metrology and Laboratory System services to maintain critical business operations.
  • Using solid analytical skills, the incumbent can recognize problems of moderate scope and complexity, and independently, develop potential solutions and courses of action according to cGMP policies and procedures.
  • Represents the work group on multi-disciplinary and cross-functional teams and uses established relationships to influence and lead teams and stakeholders with fact-based, business value knowledge.
  • Own and maintain procedures and work instructions for asset management, calibration, and maintenance. Identify improvements to asset management and metrology processes.
  • Manages metrology and lab system maintenance staff to properly maintain all equipment and instrumentation.
  • Is accountable on-boarding of assets and defining calibration ranges, tolerances, and intervals.
  • Co-ordinate with vendors and system owners for quotes, scheduling, and troubleshooting for calibration, preventive maintenance, and qualification services.
  • Completes on-demand and scheduled work orders and asset updates in CMMS systems.
  • Facilitate and support non-conformance reports in CMMS systems.
  • Manages contracts, POs and invoices to support OEM calibrations, outsourced calibration staff, equipment, instruments, standards and parts.
  • Drives Metrology and Laboratory System operating budget within target goals for all contracted services and expenses.
  • Performs periodic verifications of asset inventories.
  • Performs database updates to reflect changes found in quarterly inventory verifications (change, new assets, assets not found).
  • Periodically work on project management assignments with broadly defined objectives.
  • Solve non-routine issues, challenges, and problems within field of specialization.

Editas Medicine focuses on gene editing using CRISPR technology, which allows for precise modifications to DNA in cells. This technique has the potential to correct genetic defects that lead to various diseases. The company is engaged in the entire process of drug development, from discovering new treatments to manufacturing and bringing them to market. Editas Medicine aims to create long-lasting therapies that can greatly enhance the quality of life for patients suffering from serious illnesses. Unlike many competitors, Editas has a diverse pipeline of experimental medicines and actively shares clinical data to keep stakeholders informed. The ultimate goal is to provide effective treatments for patients worldwide, while also generating revenue through partnerships and commercialization of their genomic medicines.

Company Stage

IPO

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

10%

1 year growth

22%

2 year growth

17%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful clinical trials, like the EDIT-101 for Leber Congenital Amaurosis, demonstrate the potential for groundbreaking treatments.
  • The extension of collaborations with major pharmaceutical companies like Bristol Myers Squibb indicates strong industry validation and potential for future growth.
  • Recent investments, such as the $23.36 million from Marshall Wace LLP, reflect confidence in the company's innovative approach and financial stability.

What critics are saying

  • The highly competitive field of gene editing requires continuous innovation to maintain a leading position.
  • Regulatory hurdles and ethical concerns surrounding gene editing could delay or impede the commercialization of treatments.

What makes Editas Medicine unique

  • Editas Medicine leverages CRISPR technology to develop transformative treatments for serious diseases, setting it apart from traditional biotech firms.
  • The company's comprehensive approach, from discovery to commercialization, ensures a streamlined process for bringing genomic medicines to market.
  • Editas Medicine's strategic partnerships, such as with Bristol Myers Squibb, enhance its capabilities in developing gene-edited therapies.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE